In the twenty-first century, infertility has been regarded as the third-ranking disease following cancer and cardiovascular diseases
Background: Anastrozole is a non-steroidal fourth generation aromatase inhibitor that stops the conversion of testosterone to estradiol and has been used as empiric medical therapy for the treatment of male infertility in men with an abnormal testosterone-to-estradiol ratio <10 in order to increase endogenous testosterone levels
Anastrozole is an off-white powder with a molecular weight of 293
Because the one-sided lower bounds of the 97
I used clomid for 5 months to treat low estrogen and progesterone levels, clomid did not help
However, it is sometimes used off-label in men
Unlike the other fertility drugs, anastrazole blocks Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose-response study
6639
Aminoglutethimide is administered by intramuscular injection to induce medical adrenalectomy
Fertility drugs are the main treatment for women who are infertile due to ovulation disorders
Male factors account for approximately 50%, of which 30%–40% cannot
This aromatase inhibitor has also shown promise in treating erectile dysfunction, infertility and depression among the male population